In recent years waiving or reducing royalties on drugs for poor countries has been championed by the EU and I urge us not to be fainthearted in pressing for more concessions, whatever the complexity of the arguments, many of which I do not fully believe, and I say that as a European patent attorney, as well as a politician.
EU:ssa on puhuttu viime vuosina paljon sen puolesta, että köyhille maille tarkoitettujen lääkkeiden patenttimaksuista voitaisiin luopua tai niitä voitaisiin alentaa.